These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 20857237)

  • 1. Vascular endothelial function and hypertension: insights and directions.
    Dharmashankar K; Widlansky ME
    Curr Hypertens Rep; 2010 Dec; 12(6):448-55. PubMed ID: 20857237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Dysfunction and Hypertension.
    Konukoglu D; Uzun H
    Adv Exp Med Biol; 2017; 956():511-540. PubMed ID: 28035582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production.
    Wassmann S; Laufs U; Stamenkovic D; Linz W; Stasch JP; Ahlbory K; Rösen R; Böhm M; Nickenig G
    Circulation; 2002 Apr; 105(17):2083-91. PubMed ID: 11980689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice.
    da Silva Franco N; Lubaczeuski C; Guizoni DM; Victorio JA; Santos-Silva JC; Brum PC; Carneiro EM; Davel AP
    Pharmacol Res; 2017 Aug; 122():35-45. PubMed ID: 28539257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt-Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats.
    Yao NA; Niazi ZR; Najmanová I; Kamagaté M; Said A; Chabert P; Auger C; Die-Kakou H; Schini-Kerth V
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):573-583. PubMed ID: 32187164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats.
    Shirakura T; Nomura J; Matsui C; Kobayashi T; Tamura M; Masuzaki H
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):831-8. PubMed ID: 27198514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation.
    Silva IVG; de Figueiredo RC; Rios DRA
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil reduces aortic endothelial dysfunction and structural damage in spontaneously hypertensive rats: Role of NO, NADPH and COX-1 pathways.
    Leal MAS; Aires R; Pandolfi T; Marques VB; Campagnaro BP; Pereira TMC; Meyrelles SS; Campos-Toimil M; Vasquez EC
    Vascul Pharmacol; 2020 Jan; 124():106601. PubMed ID: 31689530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of coenzyme Q(10) in combination therapy of arterial hypertension].
    Mikhin VP; Kharchenko AV; Rosliakova EA; Cherniatina MA
    Kardiologiia; 2011; 51(6):26-31. PubMed ID: 21878067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural antioxidant compounds in risk factors for CVD.
    Kaliora AC; Dedoussis GV
    Pharmacol Res; 2007 Aug; 56(2):99-109. PubMed ID: 17572098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
    Liu L; Liu J; Huang Y
    J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Treatment of Hypertension: Effects in Endothelial Function.
    Cobos-Segarra L; Lopez-Jaramillo P; Ponte-Negretti Ci C; Villar R; Penaherrera E
    Curr Hypertens Rev; 2018; 14(2):123-127. PubMed ID: 29737254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction and hypertension in aging.
    Higashi Y; Kihara Y; Noma K
    Hypertens Res; 2012 Nov; 35(11):1039-47. PubMed ID: 22972557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in hypertension.
    Puddu P; Puddu GM; Zaca F; Muscari A
    Acta Cardiol; 2000 Aug; 55(4):221-32. PubMed ID: 11041120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and endothelial dysfunction: therapeutic approach.
    Ghiadoni L; Taddei S; Virdis A
    Curr Vasc Pharmacol; 2012 Jan; 10(1):42-60. PubMed ID: 22112351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
    Siti HN; Kamisah Y; Kamsiah J
    Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endothelium in hypertension: bystander, target or mediator?
    Lüscher TF
    J Hypertens Suppl; 1994 Dec; 12(10):S105-16. PubMed ID: 7769481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.
    Coats A; Jain S
    J Hum Hypertens; 2017 Jun; 31(6):376-381. PubMed ID: 28252041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction.
    Pinheiro LC; Oliveira-Paula GH; Portella RL; Guimarães DA; de Angelis CD; Tanus-Santos JE
    Redox Biol; 2016 Oct; 9():134-143. PubMed ID: 27521759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.